Tag Archive for: Med Ad News

Érico Braga and Fabio Rodrigues join the agency’s illustrious creative team.

ConcentricLife Founder and CEO Ken Begasse, Jr. discusses the inspiration and motivation that drives entrepreneurs with Elevate Healthcare Managing Partners Frank Powers and Lorna Weir, and Calcium CEO Judy Capano. 

Wow, this headline is ironic. I wrote it March 27, 2023. I took the photo March 29, 2023. After successfully ducking the ’vid for three years, the ’vid found me. 

This year’s honor went to IPG Health’s Renee Mellas, Group President: AREA 23, AREA 23 on Hudson, McCann Health New York, and IPG Health Canada; and Tim Hawkey, Chief Creative Officer: McCann Health New York and AREA 23.

Michael Mazza is senior director, consumer marketing for the Horizon Therapeutics brand Krystexxa.

To qualify for this annual report, agencies must have the capabilities to develop marketing strategies that target healthcare professionals (physicians, nurse practitioners, nurses, pharmacists, etc.), and/or consumers, and/or patients, and/or stakeholders such as managed market payors. Marketing strategies include the capability to create and place advertisements.

View the photo galley: It’s a wrap on another successful Manny Awards. Med Ad News recognized creative excellence in pharmaceutical and healthcare advertising across 28 categories.  

Med Ad News recognized excellence in healthcare communications at the 2023 Manny Awards, and honored Industry Person(s) of the Year Renee Mellas and Tim Hawkey. Celebrating the best in pharmaceutical and healthcare advertising, the black-tie event was held last night at The Lighthouse, Pier 61 at Chelsea Piers in New York City. Manny Awards were presented to healthcare agencies and networks achieving excellence across 28 categories.

The 34th Annual Manny Awards recognize and celebrate the best in pharmaceutical and healthcare advertising. The awards gala will be held on April 20, 2023 at The Lighthouse, Pier 61, Chelsea Piers, New York City.

As oncology drugs receive accelerated approvals, payers are questioning whether the benefits of these products outweigh the cost, spurring manufacturers to explore value-based agreements.